Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-017-2539-7
Abstract: BackgroundOur goal was to compare the survival advantage of tamoxifen (TAM) and aromatase inhibitor (AI) in female (FBC) and male breast cancer (MBC).Patients and methodsWe performed a retrospective study of 2785 FBC and 257 MBC… read more here.
Keywords: aromatase inhibitor; tam treated; breast cancer; mbc patients ... See more keywords